Inventor · disambiguated record
Klaus Gjervig Jensen
Also filed as: JENSEN KLAUS · JENSEN KLAUS G · JENSEN KLAUS GJERVIG
25 granted patents·3 pending applications·247 citations·filing 1985–2025
96Inventor score
Top patents by PatentIndex Score
28 records- 0198US11707476B2Catecholamine prodrugs for use in the treatment of parkinson's diseaseH LUNDBECK AS·Filed 2021·Granted Jul 25, 2023·12 cites·17 claims
- 0298US11110110B2Catecholamine prodrugs for use in the treatment of Parkinson's diseaseH LUNDBECK AS·Filed 2020·Granted Sep 7, 2021·15 cites·20 claims
- 0397US12226428B2Catecholamine prodrugs for use in the treatment of Parkinson's diseaseH LUNDBECK AS·Filed 2023·Granted Feb 18, 2025·6 cites·22 claims
- 0497US10729710B2Catecholamine prodrugs for use in the treatment of Parkinson's diseaseH LUNDBECK AS·Filed 2018·Granted Aug 4, 2020·21 cites·15 claims
- 0596US11858954B2Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acidH LUNDBECK AS·Filed 2021·Granted Jan 2, 2024·8 cites·31 claims
- 0696US11130775B2Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acidH LUNDBECK AS·Filed 2020·Granted Sep 28, 2021·14 cites·16 claims
- 0792US7772240B2Trans-1(6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazineLUNDBECK & CO AS H·Filed 2004·Granted Aug 10, 2010·56 cites·10 claims
- 0891US10118907B2Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophreniaH LUNDBECK AS·Filed 2017·Granted Nov 6, 2018·5 cites·9 claims
- 0991US9012453B2Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophreniaLUNDBECK & CO AS H·Filed 2013·Granted Apr 21, 2015·9 cites·28 claims
- 1091US4866077A1,2,3-Triazole and tetrazole substituted piperidine or tetrahydropyridine compounds useful as acetylcholine agonistsLUNDBECK & CO AS H·Filed 1988·Granted Sep 12, 1989·49 cites·15 claims
- 1190US10501427B2Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophreniaH LUNDBECK AS·Filed 2018·Granted Dec 10, 2019·4 cites·6 claims
- 1290US9617231B2Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophreniaH LUNDBECK AS·Filed 2015·Granted Apr 11, 2017·5 cites·3 claims
- 1390US9216961B2Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophreniaLUNDBECK & CO AS H·Filed 2015·Granted Dec 22, 2015·5 cites·11 claims
- 1489US11059798B2Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophreniaH LUNDBECK AS·Filed 2019·Granted Jul 13, 2021·3 cites·9 claims
- 1589US2025250244A1Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophreniaH LUNDBECK AS·Filed 2024·Application pending·0 cites
- 1686US8575174B2Deuterated 1-piperazino-3-phenyl-indanes for treatment of schizophreniaJORGENSEN MORTEN·Filed 2012·Granted Nov 5, 2013·9 cites·30 claims
- 1783US12421271B2Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR, 10AR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acidH LUNDBECK AS·Filed 2023·Granted Sep 23, 2025·0 cites·23 claims
- 1879US4925858AOxazole and thiazole derivatives and their use for treating disorders caused by malfunction of AcChLUNDBECK & CO AS H·Filed 1989·Granted May 15, 1990·20 cites·15 claims
- 1977US12116355B2Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophreniaH LUNDBECK AS·Filed 2021·Granted Oct 15, 2024·0 cites·7 claims
- 2073US2025381208A1Catecholamine prodrugs for use in the treatment of parkinson’s diseaseH LUNDBECK AS·Filed 2025·Application pending·0 cites
- 2161US8889142B2Chlamydia trachomatis antigens for vaccine and diagnostic useTHEISEN MICHAEL·Filed 2005·Granted Nov 18, 2014·1 cites·10 claims
- 2255US12391650B2Catecholamine prodrugs for use in the treatment of Parkinson's diseaseH LUNDBECK AS·Filed 2020·Granted Aug 19, 2025·0 cites·23 claims
- 2353US12384765B2Catecholamine prodrugs for use in the treatment of Parkinson's DiseaseH LUNDBECK AS·Filed 2020·Granted Aug 12, 2025·0 cites·27 claims
- 2451US12319710B2Catecholamine prodrugs for use in the treatment of Parkinson's diseasesH LUNDBECK AS·Filed 2020·Granted Jun 3, 2025·0 cites·29 claims
- 2551US2024025857A1New catecholamine prodrugs for use in the treatment of parkinson's diseaseH LUNDBECK AS·Filed 2021·Application pending·0 cites
- 2650US4650900AAminoalkyl substituted urea derivatives and method of treatmentLUNDBECK & CO AS H·Filed 1985·Granted Mar 17, 1987·5 cites·9 claims
- 2744US12398106B2Catecholamine carbamate prodrugs for use in the treatment of parkinson's diseaseH LUNDBECK AS·Filed 2020·Granted Aug 26, 2025·0 cites·24 claims
- 2830US4892878AOleic acid esters and pharmaceutical compositionsLUNDBECK & CO AS H·Filed 1987·Granted Jan 9, 1990·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Klaus Gjervig Jensen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →